Robert J. Jones

1984–2025 年に発表

別表記
Robert J Jones
113
論文数
26,127
被引用数
63
h 指数
103
i10 指数

被引用数

Robert J. Jones の年別被引用数1956 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 3 件1990 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 8 件1995 年: 被引用 2 件1996 年: 被引用 12 件1997 年: 被引用 5 件1998 年: 被引用 5 件1999 年: 被引用 17 件2000 年: 被引用 11 件2001 年: 被引用 17 件2002 年: 被引用 24 件2003 年: 被引用 33 件2004 年: 被引用 36 件2005 年: 被引用 36 件2006 年: 被引用 27 件2007 年: 被引用 37 件2008 年: 被引用 17 件2009 年: 被引用 31 件2010 年: 被引用 28 件2011 年: 被引用 47 件2012 年: 被引用 72 件2013 年: 被引用 148 件2014 年: 被引用 156 件2015 年: 被引用 161 件2016 年: 被引用 203 件2017 年: 被引用 270 件2018 年: 被引用 286 件2019 年: 被引用 897 件2020 年: 被引用 1,014 件2021 年: 被引用 1,010 件2022 年: 被引用 731 件2023 年: 被引用 615 件2024 年: 被引用 1,080 件2025 年: 被引用 521 件2026 年: 被引用 18 件1957〜1985 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,616 件、この内訳の 23.9%イギリス: 引用元論文 952 件、この内訳の 8.7%中国: 引用元論文 732 件、この内訳の 6.7%イタリア: 引用元論文 614 件、この内訳の 5.6%カナダ: 引用元論文 559 件、この内訳の 5.1%ドイツ: 引用元論文 534 件、この内訳の 4.9%フランス: 引用元論文 534 件、この内訳の 4.9%スペイン: 引用元論文 406 件、この内訳の 3.7%オーストラリア: 引用元論文 383 件、この内訳の 3.5%日本: 引用元論文 322 件、この内訳の 2.9%オランダ: 引用元論文 313 件、この内訳の 2.9%スイス: 引用元論文 293 件、この内訳の 2.7%
0%23.9%その他 24.5%

分野

  • Medicine72.2%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Agricultural and Biological Sciences2.8%
  • Neuroscience1.4%
  • Immunology and Microbiology1.3%
  • Health Professions0.7%
  • その他4.3%

トピック

  • Prostate Cancer Treatment and Research15.6%
  • Prostate Cancer Diagnosis and Treatment8.3%
  • PARP inhibition in cancer therapy3.7%
  • Radiopharmaceutical Chemistry and Applications3.4%
  • Renal cell carcinoma treatment3.3%
  • Cancer, Lipids, and Metabolism3%
  • その他62.7%

共著者

全論文

検索で開く
  1. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 499

  2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher M. Haqq, Howard I. Scher - New England Journal of Medicine 2011 被引用: 4,394

  3. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Hoskin, J.F. Lester, Zafar Malik, Fiona McKinna, Neil McPhail, Julian Money‐Kyrle, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh Parmar, Matthew R. Sydes - New England Journal of Medicine 2017 被引用: 1,772

  4. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono - New England Journal of Medicine 2015 被引用: 2,187

  5. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar - The Lancet 2015 被引用: 1,968

  6. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes - The Lancet 2018 被引用: 1,262

  7. First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 127

  8. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  9. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bora Gürel, Mateus Crespo, Daniel Nava Rodrigues, Shahneen Sandhu, Aude Espinasse, Peter Chatfield, Nina Tunariu, Wei Yuan, Emma Hall, Suzanne Carreira, Johann S. de Bono - The Lancet Oncology 2019 被引用: 644

  10. Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 1,918

  11. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mymoona Alzoueb, Omi Parikh, Angus Robinson, Isabel Syndikus, James Wylie, Anjali Zarkar, George Thalmann, Johann S de Bono, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Warren Grant, Katherine Hyde, Ami Sabharwal, Uschi Hofmann, Robert Dealey ほか 73 名 - The Lancet 2021 被引用: 367

  12. Genomics of lethal prostate cancer at diagnosis and castration resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Núria Porta, Emma Hall, Wei Yuan, Suzanne Carreira, Johann S. de Bono - Journal of Clinical Investigation 2019 被引用: 304

  13. A framework for the development of effective anti-metastatic agents

    著者: , , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2018 被引用: 355

  14. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2012 被引用: 1,387

  15. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joanna Gale, Stephanie Gibbs, Anna Lydon, Ashok Nikapota, Aurelius Omlin, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Sarah Rudman, Narayanan Srihari, Matthew Simms, Jacob Tanguay, Shaun Tolan, John Wagstaff, Jan Wallace, J. Wylie, Anjali Zarkar, Matthew R. Sydes, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2019 被引用: 398

  16. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2020 被引用: 527

  17. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzouebi, Omi Parikh, Angus Robinson, Amir Montazeri, James Wylie, Anjali Zarkar, Richard Cathomas, Michael D. Brown, Yatin Jain, David P. Dearnaley, Malcolm D. Mason, Duncan C. Gilbert, Ruth E. Langley, Robin Millman, David Matheson, Matthew R. Sydes, Louise Brown, Mahesh Parmar, Nicholas D. James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, D. Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, M. Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan B. McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry M. Taylor, John D. Graham ほか 80 名 - The Lancet Oncology 2023 被引用: 102

  18. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  19. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 424

  20. Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, M. Kagzi, Anna Lydon, Joe M. O’Sullivan, Sangeeta Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Srihari, Jacob Tanguay, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trial Collaborative Group - PLoS Medicine 2022 被引用: 121

  21. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith Carser, Gopalakrishnan Srinivasan, Fiona Thistlewaite, Ashraf Azzabi, Mark Beresford, David Farrugia, M. Decatris, Carys Thomas, Joanna Gale, James J McAleer, Alison Clayton, Ekaterini Boleti, T. Geldart, Santhanam Sundar, J.F. Lester, Nachi Palaniappan, Mohan Hingorani, Khaliq Rehman, Mohammad Adil Khan, Naveed Sarwar, Janine Graham, Alastair Thomson, Narayanan Srihari, Denise Sheehan, R. Srinivasan, Omar Khan, Andrew Stockdale Jane Worlding, Stergios Boussios, N Stuart, Carey MacDonald-Smith, Falalu Danwata, Duncan McLaren, Aravindhan Sundaramurthy, Anna Lydon, S. Beesley, Kathryn Lees, Mohini Varughese, Emma Gray, Angela Scott, Mark Baxter, Anna Mullard, Pasquale F. Innominato, Gaurav Kapur, Anil Kumar, Natalie Charnley, Caroline Manetta, Prabir Chakraborti, Prantik Das, Sarah Rudman, Henry F. Taylor, Christos Mikropoulos, Martin Highley, D. Muthukumar, Anjali Zarkar, Roy Vergis, Seshadri Sriprasad, Patryk Brulinski, Amanda Clarke, Richard Osbourne, Melanie Harvey, Renata Dega, Geoffrey Sparrow, U. Barthakur, Erica Beaumont, Caroline Manetta, Agnieszka Michael, Emilio Porfiri, Faisal Azam, Ravi Kodavtiganti - The Lancet Oncology 2023 被引用: 81

  22. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Prantik Das, Dan Ford, Joanna Gale, Warren Grant, Emma Gray, Peter Hoskin, Mohammad Muneeb Khan, Caroline Manetta, Neil McPhail, Joe M. O’Sullivan, Omi Parikh, Carla Perna, Carmel Pezaro, Andrew Protheroe, Angus Robinson, Sarah Maria Rudman, D.J. Sheehan, Narayanan Srihari, Isabel Syndikus, Jacob Tanguay, Carys Thomas, Salil Vengalil, John Wagstaff, James Wylie, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trials Collaborative Group - International Journal of Cancer 2022 被引用: 77

  23. Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 81

  24. Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2019 被引用: 205